Topic · page 8 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 281–320 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Rheumatology (Oxford)17 Apr 2026
The incidence, mortality and complications of systemic lupus erythematosus: a population-level cohort study from 2012 to 2023
Cohort study
Lupus16 Apr 2026
Association between interstitial fibrosis/tubular atrophy (IFTA) on kidney biopsies and anti Ro60 antibody positivity in patients with lupus nephritis (LN)
Cohort study
Rheumatology (Oxford)16 Apr 2026
Explainable machine learning for predicting infections that require hospitalization in patients with systemic lupus erythematosus
Cohort study
Lupus Sci Med15 Apr 2026
Real-world experience of anifrolumab treatment in patients with moderate-to-severe SLE: a retrospective study of patients in early access programmes
Cohort study
Pediatr Rheumatol Online J14 Apr 2026
Expert collaborative evidence-based consensus for childhood lupus nephritis diagnosis and treatment: unifying clinical approach in Saudi Arabia
Guideline or statement
Lupus13 Apr 2026
Clinical outcomes of anifrolumab after belimumab failure in systemic lupus erythematosus: A single-center case series
Cohort study
Lupus13 Apr 2026
Diagnostic performance of anti-DFS70 antibodies in excluding systemic lupus erythematosus diagnosis: An updated systematic review and meta-analysis
Meta-analysis
Lupus Sci Med10 Apr 2026
Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network
Cross-sectional study
Arthritis Care Res (Hoboken)10 Apr 2026
Comparative Performance of LFA ‐ REAL , SLEDAI , and BILAG for Detecting Clinically Meaningful Changes in Lupus Activity
Cohort study
Lupus Sci Med9 Apr 2026
Human papillomavirus (HPV) seroprevalence, cervical HPV prevalence and cervical lesions in systemic lupus erythematosus (SLE) and immunocompetent women
Cross-sectional study
Lupus Sci Med9 Apr 2026
Lectin pathway of complement in SLE: MAP-1 as a marker of haematological manifestations and elevated type I interferon activity
Cross-sectional study
RMD Open9 Apr 2026
Severe thrombocytopenia in antiphospholipid syndrome: a retrospective study of 432 patients
Cohort study
Lupus9 Apr 2026
Adoption of multimodal echocardiography in evaluating left ventricular systolic synchrony in patients with systemic lupus erythematosus
Diagnostic or prognostic study
Rheumatology (Oxford)9 Apr 2026
The influence of CYP3A5 genotype on tacrolimus pharmacokinetics in patients with SLE
Cohort study
Lupus8 Apr 2026
Prognostic risk score for end-stage kidney disease in Latin American lupus nephritis: Integrating clinical and histological data
Cohort study
Lupus Sci Med8 Apr 2026
Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials
Secondary analysis
Lupus Sci Med8 Apr 2026
Conditions identified by common comprehensive geriatric assessment measures and subsequent acute care among adults with SLE
Cohort study
Lupus Sci Med8 Apr 2026
Unsupervised clustering of clinical and laboratory features of systemic lupus erythematosus: insights from a multicentre cohort
Cohort study
Arthritis Care Res (Hoboken)7 Apr 2026
Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data
Cohort study
Arthritis Rheumatol7 Apr 2026
Subsets of Patients With Lupus Identified by Gene Expression Profiles Exhibit Differential Clinical Responsiveness to Baricitinib
Secondary analysis
Rheumatology (Oxford)6 Apr 2026
SLE-DAS responder index: a novel outcome measure with high performance for physician and patient outcomes in anifrolumab phase 2–3 trials
Meta-analysis
Lupus4 Apr 2026
Development and evaluation of frailty index for patients with systemic lupus erythematosus in China
Diagnostic or prognostic study
Rheumatology (Oxford)4 Apr 2026
Antimalarial use and extra-renal damage accrual in lupus nephritis: a longitudinal cohort study
Cohort study
Rheumatology (Oxford)4 Apr 2026
Automated whole-blood detection of IFI27 and OAS1 mRNA for distinguishing active systemic lupus erythematosus
Diagnostic or prognostic study
Arthritis Rheumatol2 Apr 2026
Dual‐Targeting BCMA – CD19 CAR ‐T Cell Therapy in Systemic Lupus Erythematosus: Single‐Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution
Mechanistic study
Lupus Sci Med1 Apr 2026
Comparison of Evans syndrome and isolated autoimmune cytopenias in SLE: a retrospective study
Cohort study
Lupus1 Apr 2026
Real-world use of anifrolumab in systemic lupus erythematosus: A retrospective study from a Danish tertiary center (2022–2025)
Cohort study
Lupus Sci Med31 Mar 2026
Pulmonary diseases in SLE: a population-based cross-sectional study
Cross-sectional study
Arthritis Res Ther30 Mar 2026
Plasma exosomal fibroblast activation protein: a novel biomarker links fatty acid metabolic dysregulation to systemic lupus erythematosus
Mechanistic study
Rheumatology (Oxford)30 Mar 2026
Assessment of the use of biologic drugs in the treatment of primary antiphospholipid syndrome
Meta-analysis
Rheumatology (Oxford)30 Mar 2026
Clinical, serological and haemodynamic factors associated with poor outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension: a multicentre retrospective study from Korea
Cohort study
Lupus28 Mar 2026
Relationship between sarcopenia and lifestyle in patients with systemic lupus erythematosus: A one-institution cross-sectional analysis
Cross-sectional study
Lupus27 Mar 2026
A conceptual model of the patient experience of cutaneous lupus erythematosus
Research article
Lupus26 Mar 2026
Patient perspectives on SLE, refractory APS, and biologic drug use during pregnancy
Cross-sectional study
Arthritis Care Res (Hoboken)25 Mar 2026
Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus
Cohort study
Lupus Sci Med24 Mar 2026
‘Getting comfortable with the uncomfortable’: barriers, facilitators and influences on reproductive health discussions from Hispanic women with systemic lupus erythematosus in the USA – a qualitative study
Research article
Lupus Sci Med24 Mar 2026
Long-term outcomes of hydroxychloroquine dose reduction in Puerto Ricans with systemic lupus erythematosus: 6-year follow-up
Cohort study
Lupus24 Mar 2026
Frequency and clinical associations of Epstein-Barr virus molecular detection in systemic lupus erythematosus: A follow-up study
Cohort study
Lupus Sci Med23 Mar 2026
Frequency and associated factors of herpes zoster infection in SLE patients from Latin America: data from the GLADEL 2.0 cohort
Cohort study
Lupus23 Mar 2026
LUNELORD: A descriptive, prospective study on the demographics, disease characteristics and health-related quality of life of patients with LUpus NEphritis and long-term ORgan damage in rheumatology clinics in the Arabian Gulf
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 281–320 of 1,848, newest first